A Madison biotech company that is developing treatments for orthopedic diseases said Wednesday that it has raised $866,000 of outside funding. Flex Biomedical Inc. will use the money to further develop its lead product, said Sal Braico, chief executive officer. Read full Journal Sentinel article here.
Flex Biomedical, a Madison firm, lands funding for joint-pain treatment
by Tech Council | Jan 27, 2011 | Featured, NEWSROOM, Tech Council News